Related Experiment Videos
Evolving management for critical pulmonary stenosis in neonates and young infants
Y F Cheung1, M P Leung, J W Lee
1Department of Paediatrics, University of Hong Kong, Hong Kong.
Insights
Transcatheter balloon valvoplasty is the optimal initial treatment for critical pulmonary stenosis in infants, offering lower mortality and reintervention rates compared to surgical methods. This approach effectively relieves obstruction with favorable long-term outcomes.
Area of Science:
- Pediatric Cardiology
- Interventional Cardiology
- Congenital Heart Disease
Background:
- Critical pulmonary stenosis in infants presents significant management challenges.
- Treatment strategies have evolved from surgical interventions to less invasive transcatheter procedures.
- Understanding the comparative outcomes of different management policies is crucial for optimizing patient care.
Purpose of the Study:
- To evaluate the immediate and long-term outcomes of infants with critical pulmonary stenosis.
- To compare the efficacy and safety of right ventricular outflow tract reconstruction, closed pulmonary valvotomy, and transcatheter balloon valvoplasty.
- To identify factors influencing mortality and reintervention rates in this patient population.
Main Methods:
- Retrospective analysis of 34 infants treated for critical pulmonary stenosis.
- Interventions included right ventricular outflow tract reconstruction (n=10), closed pulmonary valvotomy (n=13), and balloon valvoplasty (n=11).
- Outcomes assessed included procedure-related mortality, hemodynamic changes, and reintervention rates.
Main Results:
- Initial procedure-related mortality was 50% for reconstruction, 15% for closed valvotomy, and 0% for balloon valvoplasty.
- Balloon valvoplasty demonstrated a significantly lower mortality and comparable or lower reintervention rates compared to surgical methods.
- Factors associated with death included transannular patching and male sex; hypoplastic right ventricle was a risk factor for reintervention.
Conclusions:
- Transcatheter balloon valvoplasty is the optimal initial approach for critical pulmonary stenosis in infants due to its low mortality and efficacy.
- Balloon valvoplasty offers a favorable balance of relieving obstruction and a low rate of subsequent reinterventions.
- Surgical interventions, particularly those involving transannular patching, are associated with higher mortality and reintervention risks.
Abstract:
Over the years, management of critical pulmonary stenosis in young infants has evolved from surgical reconstruction of the right ventricular outflow tract and closed pulmonary valvotomy to transcatheter balloon valvoplasty. Our study aimed at evaluating how the changing policy for management had affected the immediate and long term outcomes of babies with this cardiac lesion. Interventions were made in 34 infants at a median age of 8.5 days (2-90 days). Reconstruction of the right ventricular outflow tract reconstruction was performed in 10 patients, closed pulmonary valvotomy in 13, and balloon valvoplasty in 11. Initial procedure-related mortality was 50%, 15% and 0% respectively. Multivariate analysis revealed transannular patching of the right ventricular outflow tract, and male sex, to be significant factors for death. For the 27 survivors, the ratio of right ventricular to systemic systolic pressure decreased from 1.6 +/- 0.3 to 0.3 +/- 0.2 after reconstruction of the outflow tract, 1.8 +/- 0.5 to 0.8 +/- 0.4 after closed valvotomy, and 1.8 +/- 0.6 to 0.9 +/- 0.3 after balloon valvoplasty. The decrease was significantly greater after patch reconstruction (p=0.025) that required no further reinterventions. The overall rate of reintervention for the survivors was 37% (10/27). The freedom from reintervention after closed valvotomy was 82%, 64% and 51% at 1, 5 and 10 years respectively. The figure remained at 78% at both 1 and 5 years (p=0.66) after balloon valvoplasty. The higher reintervention rate for closed valvotomy corresponded to the significantly greater residual gradient across the pulmonary valve noted on follow-up (p=0.01). Reinterventions included balloon dilation (n=6), reconstruction of the outflow tract (n=4), and 1 each of ligation of an arterial duct and systemic-pulmonary arterial shunting. The risk factor for reintervention was a hypoplastic right ventricle. In conclusion, transcatheter balloon valvoplasty appears to be the optimum initial approach in view of its low mortality, efficacy at relieving the obstruction, and low rate of reintervention.